Board Meeting-Outcome of Board Meeting
Audited Annual Financial Results for the financial year ended 31st March, 2018 and Auditors Report thereon. Dear Sir, In terms of Regulation 33of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Audited Annual Financial Results for the financial year ended 31st March, 2018 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e.... Announcement under Regulation 30 (LODR)-Dividend Updates
This is to inform you that the Board of Directors of the Company has, at its meeting held today i.e. Wednesday, 30th May, 2018 at Mumbai, recommended dividend of Rs. 0.05 (Rupees Zero and Paise Five) i.e. 5% per equity share of Re. 1/- each value for the financial year ended 31st March, 2018, subject to approval of the shareholders in the ensuing Annual General Meeting. You are requested to note the above in your records. Enclosed Herewith Kindly Find A News Release Dated 30Th May, 2018 Of The Company. You Are Requested To Note The Above In Your Records.
Enclosed herewith kindly find a News Release dated 30th May, 2018 of the Company. You are requested to note the above in your records. Audited Annual Financial Results For The Financial Year Ended 31St March, 2018 And Auditors Report Thereon.
Audited Annual Financial Results for the financial year ended 31st March, 2018 and Auditors Report thereon. Dear Sir, In terms of Regulation 33of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Audited Annual Financial Results for the financial year ended 31st March, 2018 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e.... Board Meeting-Closure of Trading Window
This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended 31st March, 2018. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2017-18.... Board Meeting - Board Meeting On Wednesday, 30Th May, 2018
This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended 31st March, 2018. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2017-18.... Marksans Pharma arm recalls Ibuprofen tablets from US
Marksans Pharma's arm, Time-Cap Laboratories Inc, is withdrawing an unspecified number of Ibuprofen tablets, manufactured in Goa, in multiple streng Shareholding for the Period Ended March 31, 2018
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir, With reference to above captioned subject, please find enclosed half yearly Compliance Certificate pursuant to Regulation 40 (9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. This information pertains to half year ended March 31, 2018. This is for your information and records.